Monika Wagner, Ph.D.
Affiliations: | 2001 | McGill University, Montreal, QC, Canada |
Area:
Civil Engineering, Environmental Engineering, Environmental SciencesGoogle:
"Monika Wagner"Cross-listing: E-Tree
Parents
Sign in to add mentor| J A. Nicell | grad student | 2001 | McGill | |
| (Horseradish peroxidase-catalyzed removal of phenols from industrial wastewaters.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Baltussen R, Marsh K, Thokala P, et al. (2019) Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 22: 1283-1288 |
| Wagner M, Samaha D, Casciano R, et al. (2019) Moving Towards Accountability for Reasonableness - A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study. International Journal of Health Policy and Management. 8: 424-443 |
| Wagner M, Samaha D, Cuervo J, et al. (2018) Applying Reflective Multicriteria Decision Analysis (MCDA) to Patient-Clinician Shared Decision-Making on the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the Spanish Context. Advances in Therapy |
| Wagner M, Samaha D, Casciano R, et al. (2018) PP149 Features Of Accountable And Reasonable Processes For Coverage Decision-Making International Journal of Technology Assessment in Health Care. 34: 125-125 |
| Wagner M, Samaha D, Casciano R, et al. (2018) Accountable and Reasonable Processes for Coverage Decision-Making for Rare Disease and Regenerative Therapies – Which Criteria Should be Considered and Why? Value in Health. 21 |
| Wagner M, Samaha D, Khoury H, et al. (2017) Development of a Framework Based on Reflective MCDA to Support Patient-Clinician Shared Decision-Making: The Case of the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the United States. Advances in Therapy |
| Wagner M, Samaha D, O'Neil B, et al. (2017) Supporting Individual Reflection and Patient-Clinician Shared Decision-Making on GEP-NET Management Options Using Reflective Multi-Criteria Decision Analysis Value in Health. 20 |
| Goetghebeur MM, Wagner M, Nikodem M, et al. (2016) Pragmatic Multicriteria Decision Analysis (MCDA) Combined With Advanced Pharmacoepidemiology for Benefit-Risk Assessments of Medicines Adapted to the Real-Life Constraints of Regulators: Development and Case Study. Therapeutic Innovation & Regulatory Science. 50: 620-631 |
| Goetghebeur M, Samaha D, O'Neil B, et al. (2016) What Matters Most? An Exploration of Decision Criteria Considered by Patients with GEP-NET and Physicians Using Holistic Multi-Criteria Decision Analysis Value in Health. 19 |
| Goetghebeur M, Samaha D, Khoury H, et al. (2016) To Treat or Watch? Identifying Drivers of Decisions for Patients with GEP-NET Using Reflective Multi-Criteria Decision Analysis Value in Health. 19 |